AAAAAA

   
Results: 1-9 |
Results: 9
Gastroesophageal reflux disease (GERD): Current agents and future perspective
Authors: Lanas, A Santolaria, S
Citation: A. Lanas et S. Santolaria, Gastroesophageal reflux disease (GERD): Current agents and future perspective, CUR PHARM D, 7(1), 2001, pp. 1-18
Diaphragm disease of the small bowel - A case without apparent nonsteroidal antiinflammatory drug use
Authors: Santolaria, S Cabezali, R Ortego, J Castiella, T Salinas, JC Lanas, A
Citation: S. Santolaria et al., Diaphragm disease of the small bowel - A case without apparent nonsteroidal antiinflammatory drug use, J CLIN GAST, 32(4), 2001, pp. 344-346
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication
Authors: Santolaria, S Guirao, R Ducons, J Cabezudo, JG Montoro, M Gomollon, F
Citation: S. Santolaria et al., Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication, J CLIN GAST, 32(1), 2001, pp. 90-91
Serum CagA and VacA antibodies and risk for peptic ulcer disease in subjects with Helicobacter pylori infection
Authors: Santolaria, S Lanas, A Benito, R Piazuelo, E Sainz, R
Citation: S. Santolaria et al., Serum CagA and VacA antibodies and risk for peptic ulcer disease in subjects with Helicobacter pylori infection, MED CLIN, 116(17), 2001, pp. 641-644
The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer
Authors: Garcia-Gonzalez, MA Lanas, A Santolaria, S Crusius, JBA Serrano, MT Pena, AS
Citation: Ma. Garcia-gonzalez et al., The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer, CLIN EXP IM, 125(3), 2001, pp. 368-375
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period
Authors: Ferrero, M Ducons, JA Sicilia, B Santolaria, S Sierra, E Gomollon, F
Citation: M. Ferrero et al., Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period, INT J ANT A, 16(3), 2000, pp. 245-248
Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users - Reply
Authors: Santolaria, S Lanas, A
Citation: S. Santolaria et A. Lanas, Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users - Reply, ALIM PHARM, 14(8), 2000, pp. 1106-1106
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer
Authors: Ducons, JA Santolaria, S Guirao, R Ferrero, M Montoro, M Gomollon, F
Citation: Ja. Ducons et al., Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer, ALIM PHARM, 13(6), 1999, pp. 775-780
Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users
Authors: Santolaria, S Lanas, A Benito, R Perez-Aisa, MA Montoro, M Sainz, R
Citation: S. Santolaria et al., Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users, ALIM PHARM, 13(11), 1999, pp. 1511-1518
Risultati: 1-9 |